Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease

By C. Heeschen, R. Lehmann, Jörg Honold, B. Assmus, Alexandra Aicher, D. Walter, H. Martin, A. Zeiher, Stefanie Dimmeler. Circulation, 2004

682 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/f086dfe1261d3c27a316d67b23f906220bb3899a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Charles E. Murry

In Molecular Biology

1. Stefanie Dimmeler
2. A. Zeiher
3. M. Laflamme
4. M. Schneider
5. Charles E. Murry
6. Nikolaos G. Frangogiannis
7. H. Ruskoaho
8. Virpi Talman

Citations in the corpus

• Mesenchymal stem cells and immunomodulation: current status and future prospects (2016, background): “All these factors limit their therapeutic benefit.(137,138) Prochymal (BM-MSCs) has yet to be granted”
• Unchain my heart: the scientific foundations of cardiac repair. (2005, background): “they are deficient in number or function? The functional capacity of bone marrow–derived cells is defective in patients with heart failure (104), and risk factors for atherosclerosis correlate”
• Regenerating the heart (2005, background): “There is evidence that patients with chronic diseases such as heart failure or diabetes have dysfunctional endothelial progenitor”